Ultra-low temperature transporter Ultra-low temperature transporter Lightweight, ultra-low temperature transporter

BioT ULT Transporter

< -70°C to -50°C Dry-Ice Based Temperature Stability System, Item No. MCS-518U

BioT™ ULT Transporter is a breakthrough portable solution for handling and transporting valuable temperature-sensitive frozen biosamples.

  • Maintains < -70°C and -50°C for over 24 hours with minimal dry ice
  • Ideal for freezing samples at a collection site.
  • Holds up to 8 standard 2-inch cryostorage boxes or 18, 250 mL cassettes
  • Lightweight, built-in finger grips for easy carrying
  • Intuitive assembly, highly durable materials

Comprised of three parts: magnetized lid, DIR dry ice retainer and base chamber. The closed-cell high-density polyethylene foam construction of the lid and base chamber is durable, non-absorbent, and remains comfortable to the touch even when loaded with dry ice and frozen materials. The magnetized lid ensure safe transport of the contents. The DIR retainer is constructed of a thermo-conductive aluminum alloy anodized for durability.

Features & Specifications


BioT™ ULT Transporter

Part Number: MCS-518U
Dimensions: Internal working area: 29.0 x 16.2 x 20.3 cm (11.4 x 6.4 x 8.0 in) External: 50.8 x 33.8 x 33 cm (20.0 x 13.3 x 13 in)
Color: Purple
-70°C to -50°C: Lid off: over 8 hours / Lid on: over 24 hours
Amount of dry ice required: 5.4 kg (12.8 lb)
Weight empty: 3.6 kg (8.0 lb)
Weight with dry ice: 9.0 kg (20.8 lb)
Working depth < -50°C: up to 20 cm (8 in) from chamber floor
Capacity: 8 standard 2-inch cryostorage boxes or 18, 250 mL cassettes

BioT™ DIR™ retainer

Part Number: MCS-518DR
Dimensions: 36.5 x 20.3 x 23.5 cm (14.4 x 8.0 x 9.25 in)
Color: Blue


This product is for laboratory research use only. Any intended use for diagnostic purposes, direct transfusion, or in the production of therapeutic product(s) or vaccines(s) may require advance regulatory clearance which is the sole responsibility of the user, as this is not a medical device that has undergone medical device registration, clearance, or approval by the U.S. Food and Drug Administration (FDA), European Union, Health Canada, or the Australian Therapeutic Goods Administration.